[1]邸师红,马　倩,代　超,等.重症监护病房脓毒血症患者病原学分布及死亡高危因素分析[J].现代检验医学杂志,2020,35(03):141-145.[doi:10.3969/j.issn.1671-7414.2020.03.038]
　DI Shi-hong,MA Qian,DAI Chao,et al.Etiology Distribution and Risk Factors of Death in Patients with Severe Sepsis in Intensive Care Unit[J].Journal of Modern Laboratory Medicine,2020,35(03):141-145.[doi:10.3969/j.issn.1671-7414.2020.03.038]
点击复制

重症监护病房脓毒血症患者病原学分布及死亡高危因素分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第35卷
期数:
2020年03期
页码:
141-145
栏目:
检验与临床
出版日期:
2020-07-20

文章信息/Info

Title:
Etiology Distribution and Risk Factors of Death in Patients with Severe Sepsis in Intensive Care Unit
文章编号:
1671-7414（2020）03-141-05
作者:
邸师红1; 马　倩1; 代　超1; 苏春霞2
（1. 宁夏医科大学总医院心脑血管病医院检验科，银川　750000； 2. 宁夏医科大学基础医学院病原生物学与免疫学系，银川　750004）
Author(s):
DI Shi-hong1;  MA Qian1;  DAI Chao1;  SU Chun-xia2
（1. Department of Clinical Laboratory, Cardiology and Cerebrovascular Disease Hospital, General Hospital of Ningxia Medical University,Yinchuan 750000,China ；2. Department of Pathogenic Biology and Immunology, School of Basic Medicine, Ningxia Medical University,Yinchuan 750004,China）
关键词:
重症监护病房; 脓毒血症; 病原菌分布; 危险因素
分类号:
R631；R446.5
DOI:
10.3969/j.issn.1671-7414.2020.03.038
摘要:
目的　探讨重症监护病房（ICU）脓毒血症患者的临床特征、病原菌的分布及死亡高危因素。方法　选取2016 年1 月～ 2018 年12 月在宁夏医科大学总医院心脑血管病医院ICU 科确诊的脓毒血症患者198 例，分析其病原菌分布 及耐药情况，根据患者预后情况分为生存组（137 例）和死亡组（61 例），对患者29 项死亡高危因素进行单因素、多 因素Logistic 回归分析。结果　共检出210 株病原菌，其中革兰阴性菌122 株（58.1%）、革兰阳性菌78 株（37.1%）、 真菌8 株（3.8%）、厌氧菌2 株（1.0%）；排前六位的病原菌依次为大肠埃希菌（20.4%）、肺炎克雷伯菌（16.2%）、 凝固酶阴性葡萄球菌（16.2%）、鲍曼不动杆菌（8.6%）、金黄色葡萄球菌（7.2%）及肠球菌属（7.6%）；210 株致病 菌中共检出99 株多重耐药菌株，耐甲氧西林金黄色葡萄球菌（MRSA）和耐甲氧西林凝固酶阴性葡萄球菌（MRCNS） 的检出率分别为31.2% 和68.0%，产超广谱β- 内酰胺酶（ESBLs）的大肠埃希菌和肺炎克雷伯菌检出率分别为49.0% 和41.4%，耐碳青霉烯类药物的菌株占21.3%；对死亡组和生存组资料进行单因素及多因素Logistic 回归分析得出： APACHE II 评分≥ 18 分、糖尿病、基础疾病≥ 2 种、多种细菌混合感染、多重耐药菌感染、脓毒性休克、多脏器功能衰竭、 侵入性治疗、NT- proBNP 和PCT 是影响患者预后的独立危险因素（P ＜ 0.05）。结论　ICU 脓毒血症患者分离的病原 菌种类多，耐药性高，导致患者死亡的因素较多，临床应加强这些危险因素的监测管理，早期制定有效的抗感染治疗方案。
Abstract:
Objective　To explore the clinical characteristics, the distribution of pathogenic bacteria and the high risk factors for death of patients with sepsis in intensive care unit (ICU). Methods　From January 2016 to December 2018, 198 patients with sepsis in ICU were selected to analyze the distribution of pathogens and drug resistance. According to the prognosis of patients, they were divided into survival group (137 cases) and death group (61 cases),and the univariate,multivariate Logistic regression analysis was carried out for the 29 high-risk factors for death. Results　A total of 210 strains of pathogenic bacteria were detected including 122 strains of Gram-negative bacteria (58.1%), 78 strains of Gram-positive bacteria (37.1%), 8 strains of fungi (3.8%), and 2 strains of anaerobic bacteria (1.0%).The top six pathogens were Escherichia coli (20.4%), Klebsiella pneumoniae (16.2%), Coagulase negative staphylococcus (16.2%), Acinetobacter baumannii (8.6%), Staphylococcus aureus (7.2%) and Enterococcus (7.6%).A total of 99 multidrug-resistant strains were detected in the 210 pathogenic bacteria. Among them, the detection rates of MRSA and MRCNS were 31.2% and 68.0%, respectively, the proportion of producing extended spectrum β-la ctamases in Escherichia coli and Klebsiella pneumoniae was 49.0% and 41.4%, respectively, and the detection rates of carbapenem resistant strains were 21.3% .The data of death group and survival group were analyzed by the univariate,multivariate Logistic regression analysis and it was concluded that the APACHE II score no less than 18 points, diabetes, more than 2 kinds of basic diseases, mixed infection of various bacteria, multiple Drug-resistant bacteria infection, septic shock, multiple organ failure,invasive treatment, NT- proBNP and PCT were the independent risk factors for the death(P ＜ 0.05). Conclusion　There were many kinds of pathogenic bacteria isolated from patients with sepsis in ICU, with high drug resistance and many factors leading to death.We should strengthen the monitoring and management of these risk factors in clinical practice, and make effective antiinfection treatment plan in the early stage.

参考文献/References:

[1]　MORELLO L G, DALLA-COSTA L M, FONTANA R M, et al. Assessment of clinical and epidemiological characteristics of patients with and without sepsis in intensive care units of a tertiary hospital[J]. Einstein (Sao Paulo, Brazil),2019,17(2) :eAO4476.
[2]　 PAOLI C J, REYNOLDS M A, SINHA M et al. Epidemiology and costs of sepsis in the united states-an analysis based on timing of diagnosis and severity level[J]. Critical Care Medicine,2018,46(12):1889-1897.
[3]　中国医师协会急诊医师分会，中国研究型医院学 会休克与脓毒症专业委员会. 中国脓毒症/ 脓毒 性休克急诊治疗指南(2018)[J]. 感染、炎症、修 复,2019,20(1):3-22. 　　 Chinese College of Emergency Physicans, Chinese Research Hospital Association, Professional Committee on Shock and Sepsis.Guidelines for emergency treatment of sepsis / septic shock in China (2018) [J]. Infection, Inflammation, Repair, 2019,20 (1): 3-22.
[4]　陈静, 龚宗炼, 葛颖, 等. 脓毒症患者感染病原学特 点及血液指标的监测分析[J]. 中华医院感染学杂 志,2019,29(17):2571-2574. 　　 CHEN Jing, GONG Zonglian,GE Ying,et al.Surveillance and analysis of pathogenic characteristics and blood indexes of sepsis patients [J]. Chinese Journal of Nosocomiology, 2019, 29 (17): 2571-2574.
[5]　LIU V X, FIELDING-SINGH V, GREENE J D, et al.The timing of early antibiotics and hospital mortality in sepsis[J]. American Journal of Respiratory and Critical Care Medicine,2017,196(7):856-863.
[6]　王喜梅, 明志浩, 尹辉明, 等. 脓毒血症的流行 病学与临床治疗进展[J]. 中华医院感染学杂 志,2017,27(15):3597-3600. 　　 WANG Ximei, MING Zhihao, YIN Huiming, et al. Progress in epidemiology and clinical treatment of sepsis [J]. Chinese Journal of Nosocomiology, 2017,27 (15):3597-3600.
[7]　　王晶, 马娟, 范云, 等.2015 ～ 2017 年陕西省人民医 院临床血流感染病原菌的分布及耐药性分析[J]. 现 代检验医学杂志,2019,34(4):87-90, 95. 　　 WANG Jing, MA Juan, FAN Yun, et al. Distribution and drug resistance of pathogenic bacteria of blood culture in Shaanxi provincial People’s Hospital from 2015 to 2017 [J]. Journal of Modern Laboratory Medicine, 2019, 34 (4): 87-90, 95.
[8]　　PEREIRA FARIA M M,WINSTON B W, SURETTE M G, et al.Bacterial DNA patterns identified using paired-end illumina sequencing of 16S rRNA genes from whole blood samples of septic patients in the emergency room and intensive care unit[J].BMC Microbiol,2018, 18(1): 79.
[9]　　贾宁, 刘丁, 罗爱武, 等.30 家医院重症监护室多 药耐药菌感染分布特征[J]. 中华医院感染学杂 志,2017,27(13):2885-2888. 　　 JIA Ning, LIU Ding, LUO Aiwu, et al. Characteristics of distribution of multidrug-resistant organisms infections in intensive care units 30 hospitals [J]. Chinese Journal of Nosocomiology, 2017,27(13):2885- 2888.
[10] 李玲, 林中华, 吕维红, 等.2015 ～ 2018 年金黄色葡 萄球菌医院感染和社区感染分布及耐药性分析[J]. 中国消毒学杂志,2019,36(9):695-698. 　　 LI Ling, LIN Zhonghua, L? Weihong, et al. Distribution and drug resistance of Staphylococcus aureus causing nosocomial infection and community-acquired infection from 2015 to 2018[J]. Chinese Journal of Disinfection, 2019,36(9):695-698.
[11] HU Fupin, Guo Yan, YANG Yang, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018[J]. European Journal of Clinical Microbiology Infectious Diseases,2019,38(12):2275-2281.
[12] 魏莲花, 李可可, 王欣, 等.2016 ～ 2017 年中国 西部肠球菌属细菌耐药性监测[J]. 中国抗生素杂 志,2019,44(10):1176-1180. 　　 WEI Lianhua, LI Keke, WANG Xin, et al. Surveillance of Enterococcus antimicrobial resistance from hospitals in Western China during 2016 ~ 2017 [J]. Chinese Journal of Antibiotics, 2019,44(10):1176-1180.
[13] PERNER A, CECCONI M, CRONHJORT M, et al. Expert statement for the management of hypovolemia in sepsis[J]. Intensive Care Medicine,2018,44(6):791-798.
[14] 邓劲, 王远芳, 吴思颖, 等.2014 ～ 2018 年四川大学 华西医院神经外科住院患者术后病原菌分布特点及 耐药分析[J]. 现代检验医学杂志,2019,34(4):75-78, 82. 　　 DENG Jin, WANG Yuanfang, WU Siying, et al. Distribution characteristics and drug resistance of postoperative pathogenis in hospitalized patients with neurosurgery in West China Hospital of Sichuan University 2014 ~ 2018 [J]. Journal of Modern Laboratory Medicine, 2019, 34 (4): 75-78, 82. [15] 毛英, 岑卓杰, 刘熠, 等. 脓毒血症患儿血清降钙素 原和血乳酸水平与病情严重程度和预后的关系[J]. 空军医学杂志,2019, 35(4): 316-319. 　　 MAO Ying, CEN Zhuojie, LIU Yi, et al. Association of serum levels of procalcitonin and blood lactate with severity and prognosis of children with sepsis [J]. Medical Journal of Air Force, 2019,35 (4): 316-319.

相似文献/References:

[1]尹良琼,余艾霞.降钙素原、胱抑素C联合检测对脓毒症患儿28天死亡率的预测价值研究[J].现代检验医学杂志,2017,32(02):153.[doi:10.3969/j.issn.1671-7414.2017.02.043]
　YIN Liang-qiong,Y Ai-xia.Predictive Value of the Combined Detection of Procalcitonin and Cystatin C in Children with Sepsis 28 Days Mortality[J].Journal of Modern Laboratory Medicine,2017,32(03):153.[doi:10.3969/j.issn.1671-7414.2017.02.043]
[2]归巧娣,刘文康,任健康,等.鲍曼不动杆菌在ICU病房传播途径及耐药性研究[J].现代检验医学杂志,2017,32(06):109.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　GUI Qiao-di,LIU Wen-kang,REN Jian-kang,et al.Transmission and Analysis of Drug Resistance of Acinetobacter Baumanii in ICU[J].Journal of Modern Laboratory Medicine,2017,32(03):109.[doi:10.3969/j.issn.1671-7414.2017.06.001]

备注/Memo

备注/Memo:
收稿日期：2019-01-01 修回日期：2020-01-31作者简介：邸师红（1988-），女，大学本科，主管技师，从事临床病原微生物检验工作，E-mail：951295070@qq.com。 通信作者：苏春霞，E-mail：chunxiasu@aliyun.com
更新日期/Last Update: 2020-07-20